Skip to end of metadata
Go to start of metadata
Date

 

Chair
StatusPlanned
Comments

Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number: https://zoom.us/u/aLIcTlITh

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
NameOrganizationPresent
Danielle BancroftBest Practice Software
Melva Peters (Scribe)Jenaker Consultingx
Jean Duteau (Chair)Duteau Designx
John HatemIndependent Consultantx
Scott Robertson Kaiser Permanentex
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCP
Isaac VetterEpic
Smile CDR
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDP
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHAx
Tim McNeilSurescriptsx
Kim RobertsPharmacy HIT Collaborative
Kent BulzaWell Healthx
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRxx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna
James Tcheng

Peter Muir

Joe KellySurescripts

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Review

Project Proposals

  • PSS-2123 - Getting issue details... STATUS - Imaging ServiceRequest - no requirement for Pharmacy to be involved

Project Scope Statements

  • PSS-2113 - Getting issue details... STATUS - ValueBased Performance Reporting Implementation Guide - sponsored by CQI
    • no requirement for Pharmacy to be involved

External Meeting Review

Catalog Updates (John Hatem)

  • - no updates

Workflow Update (John Hatem) 

  • - no meeeting

Healthcare Product Update (John Hatem)

  • - discussing trackers - 1 tracker to be reviewed

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

  • - unaware of meetings
    • John and Scott have been reviewing documents

NCPDP Updates (NCPDP Members)

All NCPDP Meeting information can be obtained at https://dms.ncpdp.org/

  • - WG meeting Nov 2-4, 2022
    • Shelly - NCPDP Task Group looking at writing a paper on Med List and Med Reconciliation
      • will be creating a FHIR profile for Standardized Medication Profile (SMP) - looking for funding

Projects

Pharmacist Consult Note (Scott)

  • - Ballot Reconciliation Status.  
    • Scott has triaged the comments.  Several typo/editorial; others will require review and potential changes. 
    • 3 comments against Pharmacy Templates are actually for Consult Note.  will be transferred.
  •  
    • 3 comments to be cloned across to the Consult Note
    • Scott has reviewed the comments 
    • Have been reviewing at NCPDP TG
    • Voting must take place at HL7
    • OTHER-2367 - re-opened as vote must be done in Pharmacy WG
      • Medication is listed as "should", but needs to be "shall"
      • Pharmacists may get consult notes that don't include medications - so will not change
      • Motion:  Scott Robertson - Shelly Spiro - 8-0-1 - Carried
    • OTHER-2357 - which CDA Structure should be used to include pharmacist recommendations
      • "Assessment and plan" will include pharmacists impressions and recommendations - in both of CDA and FHIR - required
      • Plan of treatment section - details pharmacist recommendations
      • Question answered - See Section 5.2.2
      • No vote required
    • OTHER-2356 - Medication Section - suggest change to Required
      • not persuasive with Mod - include an example of why the medication is not present in the IG to clarify
      • Motion - Scott Robertson - John Hatem - 9-0-0 Carried
    • OTHER-2355 - US Realm Header - FHIR Composition
      • agree to add
      • Motion - Scott Robertson - Stephen Chu 9-0-0 Carried 
    • Scott will group issues and put out a block vote for some

Pharmacy Templates

  •  Ballot Reconciliation Status.  Giorgio will present reconciliation work in a future meeting
  • - no discussion

Specialty Medication Enrolment IG

  • - Ballot Reconciliation Status. 
    • Frank McKinney will present reconciliation work in a future meeting
  • no discussion

Withdrawal of HL7 Version 3 Standard: Pharmacy; Medication Statement, Release 1

  •  
    • one vote against appears to confuse the V3 item with FHIR MedicationStatement.  Balloter to be contacted
  •   - have reached out to submitter of 1 negative comment - no response
    • MOTION to find negative comment not persuasive as this is V3 Medication Statement - Melva Peters - Scott Robertson - 9-0-0 Carried
    • Jean Duteau to create reconciliation spreadsheet and post and let Lynn know to withdraw

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

  • FHIR-37980 - new text re: boundaries and scope for SupplyDelivery
    • New wording proposed from Pharmacy and added to Jira Issue

Any Other Business

Next meeting: